Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer - Contacts and Locations

Home

Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer

This study has been completed.

Study NCT00281866. Last updated on May 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00281866

Locations


United States, Maryland
	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
	Baltimore, Maryland, United States, 21231-2410

Spain
	Hospital Universitario 12 de Octubre
	Madrid, Spain, 28041

Sponsors and Collaborators

Sidney Kimmel Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Michael K. Gibson, MD	Sidney Kimmel Comprehensive Cancer Center